HQY Stock Cash Flow Statements

HealthEquity Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

HealthEquity Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31	2022-10-31	2022-07-31	2022-04-30	2022-01-31	2021-10-31	2021-07-31	2021-04-30	2021-01-31	2020-10-31	2020-07-31	2020-04-30	2020-01-31	2019-10-31	2019-07-31	2019-04-30	2019-01-31	2018-10-31	2018-07-31	2018-04-30	2018-01-31	2017-10-31	2017-07-31	2017-04-30	2017-01-31	2016-10-31	2016-07-31	2016-04-30	2016-01-31	2015-10-31	2015-07-31	2015-04-30	2015-01-31	2014-10-31

cash flows from operating activities:
net income	59,854,000	53,915,000	26,365,000	5,703,000	35,822,000	28,813,000	26,364,000	14,673,000	10,581,000	4,094,000	-209,000	-1,641,000	-10,654,000	-13,639,000	-32,818,000	-5,038,000	-3,818,000	-2,615,000	5,367,000	1,789,000	-148,000	1,826,000	-190,000	-21,334,000	19,366,000	41,822,000	13,119,000	15,686,000	22,517,000	22,577,000	5,905,000	10,482,000	16,946,000	14,029,000	4,062,000	6,008,000	8,233,000	8,073,000	3,128,000	4,087,000	4,421,000	4,977,000	1,371,000	3,049,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	38,454,000	38,741,000	39,182,000	40,721,000	43,610,000	38,938,000	37,911,000	37,780,000	38,346,000	39,041,000	40,475,000	40,500,000	40,740,000	39,486,000	38,824,000	33,545,000	33,051,000	31,768,000	30,419,000	29,379,000	28,599,000	27,507,000	26,561,000	19,069,000	4,949,000	4,773,000	4,687,000	4,582,000	4,396,000	4,520,000	4,810,000	4,006,000	3,654,000	3,482,000	3,643,000	3,418,000	3,178,000	2,947,000	2,871,000	2,065,000	1,915,000	1,750,000	1,703,000	1,544,000
stock-based compensation	19,068,000	14,336,000	21,708,000	21,123,000	21,574,000	32,020,000	17,212,000	21,662,000	20,073,000	18,204,000	12,304,000	18,170,000	18,154,000	13,986,000	11,050,000	13,284,000	15,617,000	12,799,000	12,550,000	11,479,000	11,438,000	7,396,000	8,650,000	17,576,000	7,590,000	6,028,000	5,596,000	5,734,000	5,488,000	4,239,000	3,842,000	3,665,000	3,793,000	3,010,000	1,999,000	2,068,000	2,509,000	1,822,000	1,629,000	1,483,000	1,677,000	1,094,000	1,732,000	325,000
amortization of debt discount and issuance costs	268,000	265,000		377,000	725,000	703,000		689,000	679,000	782,000		815,000	827,000	812,000
deferred taxes	29,387,000	1,324,000	-2,771,000	-4,861,000	184,000	-5,388,000	1,933,000	-7,790,000	-7,400,000	-738,000	-6,616,000	-3,007,000	-3,088,000	-4,470,000	-14,665,000	-4,714,000	-7,294,000	3,243,000	-4,159,000	-405,000	-4,354,000	3,786,000	2,975,000	-7,178,000	326,000	7,542,000	14,000	-1,957,000	362,000	1,989,000	-787,000	394,000	1,481,000	3,218,000				34,000					-433,000	179,000
changes in operating assets and liabilities:
accounts receivable	5,092,000	1,750,000	-11,294,000	1,742,000	-2,236,000	-1,325,000	-8,712,000	-3,600,000	5,833,000	-1,579,000	-9,119,000	2,710,000	-4,586,000	1,425,000	-1,114,000	-9,860,000	245,000	-475,000	-8,476,000	8,215,000	-704,000	552,000
prepaid expenses and other current and non-current assets
operating lease right-of-use assets	1,690,000	1,649,000	1,660,000	1,639,000	1,624,000	1,741,000	1,949,000	1,647,000	4,750,000	1,844,000	2,075,000	2,052,000	2,083,000	2,034,000	6,291,000	2,884,000	2,691,000	3,369,000	2,806,000	2,781,000	2,459,000	3,104,000	2,878,000	2,054,000	651,000	635,000
accrued compensation	7,178,000	-42,210,000	20,919,000	9,545,000	13,051,000	-25,757,000	17,780,000	-154,000	10,706,000	-25,381,000	10,348,000	-6,657,000	8,758,000	-13,731,000	14,441,000	-7,459,000	7,109,000	-17,748,000	16,022,000	-1,397,000	9,070,000	-22,924,000
accounts payable, accrued liabilities, and other current liabilities	-7,207,000	3,422,000	-15,869,000	17,490,000	9,614,000	-2,347,000	2,159,000	-6,333,000	4,020,000	-50,000	6,497,000	-7,584,000	-1,530,000	-24,056,000	31,845,000	-3,810,000	-29,832,000	-381,000	38,358,000
operating lease liabilities, non-current	-1,983,000	-1,968,000	-1,983,000	-1,956,000	-2,095,000	-1,745,000	-1,814,000	-1,791,000	-6,254,000	-1,921,000	-1,831,000	-1,807,000	-1,773,000	-1,821,000	-2,604,000	-2,252,000	-2,248,000	-2,308,000	-2,442,000	-2,638,000	-2,678,000	-3,045,000
other long-term liabilities	-987,000	-784,000	-2,313,000	-222,000	-4,626,000	3,000	1,559,000	4,619,000	-215,000	599,000	2,950,000	-3,973,000	-188,000	-266,000	-657,000	4,418,000	2,720,000	-1,104,000	-2,705,000	3,235,000	4,350,000	1,127,000					132,000	143,000	227,000	71,000	169,000	159,000	367,000	244,000	161,000	219,000
net cash from operating activities	135,866,000	64,738,000	75,748,000	90,550,000	108,129,000	65,429,000	77,073,000	57,108,000	77,107,000	31,538,000	55,491,000	47,933,000	40,149,000	7,077,000	50,557,000	22,272,000	37,248,000	30,918,000	60,902,000	52,055,000	53,636,000	15,026,000	30,940,000	17,239,000	31,495,000	25,336,000	32,637,000	28,145,000	29,936,000	22,704,000	19,819,000	22,122,000	24,185,000	15,576,000	14,562,000	15,491,000	13,426,000	2,112,000	7,769,000	11,480,000	5,521,000	1,771,000	4,467,000	4,229,000
capex	-773,000	-86,000	-328,000	-294,000	-741,000	-721,000	-560,000	-544,000	-458,000	-132,000	-400,000	-587,000	-1,229,000	-1,155,000	-1,624,000	-932,000	-3,862,000	-2,490,000	-1,705,000	-2,401,000	-1,476,000	-6,543,000	0	165,000	-18,000	21,000	0	-8,000	-477,000	491,000	0	185,000	-80,000	133,000	0	190,000	371,000	8,000	0	0	0	0	0	0
free cash flows	135,093,000	64,652,000	75,420,000	90,256,000	107,388,000	64,708,000	76,513,000	56,564,000	76,649,000	31,406,000	55,091,000	47,346,000	38,920,000	5,922,000	48,933,000	21,340,000	33,386,000	28,428,000	59,197,000	49,654,000	52,160,000	8,483,000	30,940,000	17,404,000	31,477,000	25,357,000	32,637,000	28,137,000	29,459,000	23,195,000	19,819,000	22,307,000	24,105,000	15,709,000	14,562,000	15,681,000	13,797,000	2,120,000	7,769,000	11,480,000	5,521,000	1,771,000	4,467,000	4,229,000
cash flows from investing activities:
purchases of software and capitalized software development costs	-10,407,000	-16,057,000	-13,229,000	-12,571,000	-12,223,000	-13,106,000	-10,710,000	-11,619,000	-9,791,000	-9,003,000	-9,867,000	-11,091,000	-10,580,000	-13,635,000	-13,675,000	-16,936,000	-16,628,000	-15,469,000	-14,258,000	-15,455,000	-10,012,000	-11,775,000
purchases of property and equipment	-773,000	-86,000	-328,000	-294,000	-741,000	-721,000	-560,000	-544,000	-458,000	-132,000	-400,000	-587,000	-1,229,000	-1,155,000	-1,624,000	-932,000	-3,862,000	-2,490,000	-1,705,000	-2,401,000	-1,476,000	-7,511,000
acquisitions of hsa portfolios			0	0	-196,118,000	-256,123,000	0
net cash from investing activities	-11,180,000	-16,143,000	-13,557,000	-12,865,000	-209,082,000	-269,950,000	-11,270,000	-15,420,000	-10,249,000	-9,135,000	-10,276,000	-13,527,000	-21,121,000	-74,203,000	-471,301,000	-79,678,000	-20,467,000	-67,801,000	-20,234,000	-21,034,000	-30,402,000	-25,294,000
cash flows from financing activities:
principal payments on long-term debt			-25,000,000				0	0	0	-54,375,000	-2,188,000	-2,187,000	-2,188,000	-2,187,000	0	-987,500,000	0	-15,625,000	-15,625,000	-7,813,000	-207,813,000	-7,812,000
repurchases of common stock	-66,745,000	-59,065,000	-62,980,000
proceeds from long-term debt			0	511,875,000	175,000,000	50,000,000																	0
settlement of client-held funds obligation	-855,000	1,451,000	-4,808,000	4,016,000	-282,000	-546,000	1,048,000	-22,000	-2,593,000	2,432,000	976,000	-588,000	-3,326,000	2,335,000	1,079,000	1,071,000	-2,283,000	-353,000	327,000	6,103,000	-6,516,000	-3,776,000
proceeds from exercise of common stock options	9,481,000	965,000	4,382,000	830,000	1,899,000	2,317,000	3,067,000	2,050,000	438,000	916,000	66,000	1,680,000	2,125,000	2,811,000	2,026,000	1,056,000	2,483,000	4,189,000	4,077,000	1,674,000	1,594,000	1,223,000	4,005,000	778,000	2,335,000	4,229,000	1,591,000	2,869,000	8,302,000	10,167,000	2,244,000	5,248,000	3,243,000	3,829,000	2,596,000	3,418,000	983,000	145,000	164,000	598,000	660,000	493,000	33,000	14,000
net cash from financing activities	-108,119,000	-56,649,000	-88,406,000	-82,415,000	176,617,000	51,771,000	4,115,000	2,028,000	-2,155,000	-51,027,000	-1,146,000	-1,095,000	-3,389,000	2,959,000	-2,971,000	-47,219,000	200,000	444,853,000	-11,221,000	-575,000	74,583,000	-10,365,000	11,330,000	988,960,000	461,216,000	4,229,000	1,591,000	2,869,000	8,302,000	10,167,000	2,244,000	5,248,000	3,243,000	3,829,000	3,321,000	5,078,000	5,954,000	9,423,000	242,000	1,475,000	30,506,000	4,424,000	488,000	84,809,000
increase in cash and cash equivalents			-26,215,000	-4,730,000			69,918,000	43,716,000			44,069,000	33,311,000	15,639,000	-64,167,000	-423,715,000	-104,625,000	16,981,000	407,970,000	29,447,000	30,446,000							72,468,000	27,199,000	32,863,000	29,473,000	15,105,000	14,646,000	14,636,000	15,131,000	14,608,000	16,177,000	16,403,000	9,125,000					3,151,000	86,968,000
beginning cash and cash equivalents	0	295,948,000	0	0	0	403,979,000	0	0	0	254,266,000	0	0	0	225,414,000	0	0	0	328,803,000	0	0	0	191,726,000	0	0	0	361,475,000	0	0	0	199,472,000	0	0	0	139,954,000	0	0	0	83,641,000	0	0	0	111,005,000	0	0
ending cash and cash equivalents	16,567,000	287,894,000	-26,215,000	-4,730,000	75,664,000	251,229,000	69,918,000	43,716,000	64,703,000	225,642,000	44,069,000	33,311,000	15,639,000	161,247,000	-423,715,000	-104,625,000	16,981,000	736,773,000	29,447,000	30,446,000	97,817,000	171,093,000	17,169,000	-640,603,000	485,850,000	329,310,000	72,468,000	27,199,000	32,863,000	228,945,000	15,105,000	14,646,000	14,636,000	155,085,000	14,608,000	16,177,000	16,403,000	92,766,000	-1,368,000	-23,842,000	33,990,000	74,861,000	3,151,000	86,968,000
other assets		-5,702,000	-118,000	-2,327,000	-9,118,000	-227,000	-19,970,000	-4,294,000	-4,012,000	-4,514,000	-2,189,000	8,355,000	-8,863,000	7,317,000	-12,424,000	-748,000	18,387,000	2,249,000	-28,148,000	6,496,000	5,173,000	-8,360,000
decrease in cash and cash equivalents		-8,054,000				-152,750,000				-28,624,000												-20,633,000
amortization of debt issuance costs																	1,254,000	1,228,000	1,284,000	1,285,000	1,332,000	1,201,000
loss on extinguishment of debt			0				0	0	0	1,157,000					5,000
other non-cash items											-1,000	0			1,982,000	2,000	-1,645,000	893,000	26,000	-198,000	431,000	1,494,000
payment of debt issuance costs			0												-74,000
impairment of right-of-use assets
change in fair value of contingent consideration															0	-3,158,000
gains on equity securities
business combinations, net of cash acquired
proceeds from sale of equity securities															0	0
proceeds from follow-on equity offering, net of payments for offering costs															-2,000	0	0	456,642,000	0	-539,000
payment of contingent consideration
acquisition of intangible member assets												-1,849,000	-9,312,000	-59,413,000	-1,002,000	-61,810,000	-2,344,000	-309,000	-4,271,000	-3,178,000	-18,914,000	-6,008,000
acquisitions, net of cash acquired															-455,000,000	0	0	-49,533,000
proceeds from issuance of long-term debt
purchases of equity securities
(gains) losses on marketable equity securities
purchases of marketable securities
proceeds from sale of marketable securities
gains on marketable equity securities
accounts payable																					2,415,000	3,632,000	-4,363,000							87,000									596,000
accrued liabilities and other current liabilities																					-3,747,000	-2,270,000	-7,896,000	8,713,000	3,173,000	1,769,000
supplemental cash flow data:
interest expense paid in cash																						10,749,000		148,000	51,000	50,000
income taxes paid in cash, net of refunds received																						733,000		8,000
supplemental disclosures of non-cash investing and financing activities:
exercise of common stock options receivable																								-66,000	-54,000	141,000		-107,000	-662,000	797,000
purchases of property and equipment included in accounts payable or accrued liabilities at period end																						968,000		165,000	-18,000	21,000		-8,000	-477,000	491,000		185,000	-80,000	133,000		190,000	371,000	8,000
purchases of software and capitalized software development costs included in accounts payable or accrued liabilities at period end																						1,537,000		-171,000	329,000	158,000		-19,000	58,000	117,000		432,000	-72,000	141,000		69,000	5,000	111,000
(gains) losses on marketable equity securities and other
proceeds from follow-on offering, net of payments for offering costs																																							0	0
purchases of intangible member assets
purchases of marketable equity securities and other
proceeds from follow-on equity offering, net of payment for offering costs
equity-based acquisition consideration
purchases of intangible member assets accrued during the period
unrealized (gains) losses on marketable equity securities and other
follow-on equity offering costs accrued during the period
debt issuance costs accrued during the period
purchases of marketable equity securities
bad debt expense
loss on disposal of software development costs and other																											89,000
accrued liabilities																											2,580,000	395,000	-825,000	881,000	-2,102,000	1,686,000	275,000	625,000	63,000	839,000	-337,000	1,164,000		-9,000
purchase of marketable securities
purchase of property and equipment
purchase of software and capitalized software development costs
acquisition of a business
tax benefit from exercise of common stock options																																			725,000	1,660,000	4,971,000	9,278,000	242,000	1,030,000	6,354,000	3,931,000	455,000	1,118,000
inventories																												-1,000	14,000	38,000	-46,000	170,000	190,000	63,000				22,000
unrealized losses on marketable securities and other																													-16,000	102,000
amortization of deferred financing costs and loss on other investments
purchases of other investments
deferred financing costs paid
amortization of deferred financing costs and other																																70,000	-14,000	41,000
purchases of intangible member assets accrued at period end																																3,159,000
loss on revaluation of redeemable convertible preferred stock derivative																																											0
loss on other investments
amortization of deferred financing costs																																			15,000	17,000	18,000	18,000
purchase of other investments
dividend payments
proceeds from initial public offering, net of payments for offering costs																																											0
proceeds from exercise of common stock warrants																																											0	37,000
deferred financing costs
other long-term liability																																						583,000
loss on revaluation of warrant liability
imputed interest on notes payable
restricted cash
due to trust
income taxes payable
deferred rent																																											7,000	46,000
note receivable from shareholder
repayment of notes payable
repurchase of redeemable convertible preferred stock and convertible preferred stock
proceed from initial public offering, net of payment for offering costs
conversion of preferred stock to common stock
preferred stock accretion
reclassification of series d-3 redeemable convertible preferred stock derivative liability
common stock warrants exercised																																												21,000
deferred offering costs
series d-3 redeemable convertible preferred stock dividend
prepaid expenses
letter of credit cash deposit
revaluation of redeemable convertible preferred stock derivative

We provide you with 20 years of cash flow statements for HealthEquity stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HealthEquity stock. Explore the full financial landscape of HealthEquity stock with our expertly curated income statements.

The information provided in this report about HealthEquity stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.